Can a pharmaceutical manufacturer face liability for failing to bring an allegedly safer drug to market sooner, even when the drug it already sells is not defective?
The wave of litigation targeting Apple over its AirTag tracking devices is a useful case study for any company that manufactures or sells a product that could conceivably be misused…
As we previously reported, the CPSC has been undergoing significant changes amid a broader agency shakeup. On August 7, 2026, the Senate confirmed Karen Sessions of Texas and Brien…
If your company makes products, integrates software into products, or operates in a complex global supply chain that touches the European Union, a major overhaul of EU product liability law…
On May 21, 2026, the California Occupational Safety and Health Standards Board (OSHSB) granted in part Petition No. 609, kickstarting a process that may result in the ban of fabrication…
If your company imports consumer products into the United States, a significant new regulatory requirement will take effect on July 8. The U.S. Consumer Product Safety Commission (CPSC) now requires…
State regulation of per- and polyfluoroalkyl substances (PFAS), commonly known as “forever chemicals,” continues to accelerate nationwide. In April 2026, New Jersey enacted the Protecting Against Forever Chemicals Act (the…
Gilead Tenofovir “Alternative Product” Duty at the CA Supreme Court: What It Means for Manufacturers
A California Court of Appeal decision recognizing an unusual and potentially far-reaching negligence duty for product manufacturers is now before the California Supreme Court. In the
Gilead Tenofovir Cases…
Texas made a targeted amendment to one of its key products liability statutes governing the rental and leasing of motor vehicles. The Texas Legislature recently amended Section 82.009 of the…
A recent ruling from the Texas Supreme Court reinforces a demanding evidentiary standard in premises liability cases and reminds plaintiffs that circumstantial evidence of a hazard’s cause is not the…